Logo image of URGN

UROGEN PHARMA LTD (URGN) Stock Analyst Earnings Estimates

NASDAQ:URGN - Nasdaq - IL0011407140 - Common Stock - Currency: USD

20.72  +0.84 (+4.23%)

After market: 20.5 -0.22 (-1.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
URGN revenue by date.URGN revenue by date.
64.36M
33.97%
82.713M
28.52%
90.398M
9.29%
126.38M
39.80%
264.06M
108.94%
404.84M
53.31%
439.96M
8.68%
689.66M
56.76%
871.38M
26.35%
1.269B
45.63%
1.396B
10.01%
EBITDA
YoY % growth
URGN ebitda by date.URGN ebitda by date.
-78.12M
14.59%
-64.734M
17.14%
-96.453M
-49.00%
-103.946M
-7.77%
-30.934M
70.24%
106.7M
444.93%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
URGN ebit by date.URGN ebit by date.
-79.04M
14.36%
-65.536M
17.09%
-96.782M
-47.68%
-78.42M
18.97%
-2.126M
97.29%
137.68M
6,575.65%
173.3M
25.87%
391.58M
125.95%
559.51M
42.89%
915.09M
63.55%
1.011B
10.48%
Operating Margin
URGN operating margin by date.URGN operating margin by date.
-122.81%-79.23%-107.06%-62.05%-0.81%34.01%39.39%56.78%64.21%72.11%72.42%
EPS
YoY % growth
URGN eps by date.URGN eps by date.
-4.78
3.57%
-3.73
22.02%
-3.23
13.40%
-2.97
7.99%
-1.32
55.60%
0.70
152.89%
1.35
92.90%
3.52
161.17%
4.95
40.83%
8.00
61.55%
8.33
4.08%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.85
6.55%
-0.66
-20.55%
-0.48
39.60%
-0.68
25.72%
Revenue
Q2Q % growth
23.598M
8.01%
34.365M
36.35%
47.751M
94.39%
42.975M
112.18%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-34.156M
-32.19%
-25.017M
-42.58%
-17.316M
37.39%
-19.728M
46.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.92
5.15%
-0.82-0.10-12.75%
Q4 2024
Q2Q % growth
-0.80
-11.11%
-0.73-0.07-8.93%
Q3 2024
Q2Q % growth
-0.55
19.12%
-0.830.2834.01%
Q2 2024
Q2Q % growth
-0.91
11.65%
-0.85-0.06-7.23%
Q1 2024
Q2Q % growth
-0.97
25.38%
-0.88-0.09-9.81%
Q4 2023
Q2Q % growth
-0.72
40.98%
-0.69-0.03-3.81%
Q3 2023
Q2Q % growth
-0.68
39.98%
-0.860.1821.20%
Q2 2023
Q2Q % growth
-1.03
12.71%
-1.160.1311.11%
Q1 2023
Q2Q % growth
-1.30
-4.00%
-1.360.064.17%
Q4 2022
Q2Q % growth
-1.22
3.94%
-1.09-0.13-11.44%
Q3 2022
Q2Q % growth
-1.13
16.07%
-1.180.053.97%
Q2 2022
Q2Q % growth
-1.18
-0.85%
-1.300.129.27%
Q1 2022
Q2Q % growth
-1.25
-6.84%
-1.360.118.09%
Q4 2021
Q2Q % growth
-1.27
7.97%
-1.20-0.07-5.97%
Q3 2021
Q2Q % growth
-1.35
-3.05%
-1.32-0.03-2.47%
Q2 2021
Q2Q % growth
-1.17
18.75%
-1.15-0.02-1.87%
Q1 2021
Q2Q % growth
-1.17
34.64%
-1.320.1511.42%
Q4 2020
Q2Q % growth
-1.38
25.81%
-1.400.021.34%
Q3 2020
Q2Q % growth
-1.31
-23.58%
-1.520.2114.09%
Q2 2020
Q2Q % growth
-1.44
-33.33%
-1.610.1710.77%
Q1 2020
Q2Q % growth
-1.79
-61.26%
-1.65-0.14-8.62%
Q4 2019
Q2Q % growth
-1.86 -1.73-0.13-7.34%
Q3 2019
Q2Q % growth
-1.06 -1.310.2519.28%
Q2 2019
Q2Q % growth
-1.08 -1.240.1613.13%
Q1 2019
Q2Q % growth
-1.11 -1.160.054.42%
URGN Yearly EPS VS EstimatesURGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
20.254M
7.84%
23.26M-3.006M-12.92%
Q4 2024
Q2Q % growth
24.565M
4.40%
26.147M-1.582M-6.05%
Q3 2024
Q2Q % growth
25.204M
20.87%
24.688M516K2.09%
Q2 2024
Q2Q % growth
21.848M
3.35%
24.442M-2.594M-10.61%
Q1 2024
Q2Q % growth
18.781M
9.24%
21.809M-3.028M-13.88%
Q4 2023
Q2Q % growth
23.53M
30.07%
23.02M510K2.22%
Q3 2023
Q2Q % growth
20.852M
29.52%
20.43M422K2.07%
Q2 2023
Q2Q % growth
21.139M
27.34%
20.523M616K3.00%
Q1 2023
Q2Q % growth
17.192M
26.78%
17.525M-333K-1.90%
Q4 2022
Q2Q % growth
18.09M
11.87%
18.882M-792K-4.19%
Q3 2022
Q2Q % growth
16.1M
41.85%
20.549M-4.449M-21.65%
Q2 2022
Q2Q % growth
16.6M
27.40%
17.576M-976K-5.55%
Q1 2022
Q2Q % growth
13.56M
81.04%
15.482M-1.922M-12.41%
Q4 2021
Q2Q % growth
16.17M
102.89%
16.822M-652K-3.88%
Q3 2021
Q2Q % growth
11.35M
228.03%
15.728M-4.378M-27.84%
Q2 2021
Q2Q % growth
13.03M
3,421.62%
11.955M1.075M8.99%
Q1 2021
Q2Q % growth
7.49M 9.234M-1.744M-18.89%
Q4 2020
Q2Q % growth
7.97M 7.72M250K3.24%
Q3 2020
Q2Q % growth
3.46M 3.405M55K1.62%
Q2 2020
Q2Q % growth
370K
1,750.00%
264.517K105.483K39.88%
URGN Yearly Revenue VS EstimatesURGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.52% -4.22% 0.47% -0.23%
Revenue0% -6.71% 2.31% 2.18%